Physician

Surya K Challa, M.D.

According to 2025 Medicare claims, Surya Challa, M.D. (NPI: 1730162819) practices general psychiatry in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is ENVISIONS OF LIFE LLC (NPI: 1881788818; TIN: 200966425) and primary practice location at 27407-3079.

Challa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 69 traditional Medicare patients, billed 404 HCPCS/CPT codes, and received $26,269 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 2,620 prescription claims across 118 beneficiaries totaling $991,736 in drug costs, led by Invega Sustenna (Paliperidone Palmitate). Open Payments data shows 30 records totaling $816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $95,005 to $26,269. In contrast, Part D prescription costs have risen steadily, from $255,074 to $991,736. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$50K$100K2015 Medicare payment: $95,005 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $99,556 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $63,065 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $30,473 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $20,147 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $36,036 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $24,351 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $21,594 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $26,269 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155471,527$95,005
20165921,727$99,556
20173771,018$63,065
2018195543$30,473
2019109338$20,147
2020N/RN/RN/R
2021118605$36,036
202286417$24,351
202369326$21,594
202469404$26,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$496K$992K2015 Drug cost: $255,074 (USD; Tot_Drug_Cst)2016 Drug cost: $465,687 (USD; Tot_Drug_Cst)2017 Drug cost: $465,115 (USD; Tot_Drug_Cst)2018 Drug cost: $243,935 (USD; Tot_Drug_Cst)2019 Drug cost: $160,028 (USD; Tot_Drug_Cst)2020 Drug cost: $260,379 (USD; Tot_Drug_Cst)2021 Drug cost: $348,600 (USD; Tot_Drug_Cst)2022 Drug cost: $494,673 (USD; Tot_Drug_Cst)2023 Drug cost: $750,582 (USD; Tot_Drug_Cst)2024 Drug cost: $991,736 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151943,098$255,074
20163754,259$465,687
20173913,989$465,115
20181882,519$243,935
20191191,475$160,028
202069802$260,379
20211111,288$348,600
20221131,461$494,673
20231232,365$750,582
20241182,620$991,736

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90792Psychiatric diagnostic evaluation with medical services1414$129
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2428$88
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes55331$58

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Invega SustennaPaliperidone Palmitate842,310$253,341
IngrezzaValbenazine Tosylate17487$122,250
UzedyRisperidone27879$107,119
Abilify MaintenaAripiprazole26750$72,499
AristadaAripiprazole Lauroxil19828$55,441

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$816Alkermes, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Surya K. Challa, M.D.?

Tedicare shows public-source Medicare data for Surya K. Challa, M.D. (NPI 1730162819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Surya K. Challa, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Surya K. Challa, M.D.?

Surya K. Challa, M.D. is linked to ENVISIONS OF LIFE LLC (billing NPI 1881788818) in the available physician profile data.

Does Surya K. Challa, M.D. have Open Payments data?

Surya K. Challa, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.